On-admission serum uric acid predicts outcomes after acute myocardial infarction: Systematic review and metaanalysis of prognostic studies

Croatian Medical Journal

Volumn 53, Issue 2, 2012, Pages 162-172

  Trkulja, Vladimir ^a   Car, Siniša ^b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b Varazdin General Hospital   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

URIC ACID;

ACUTE HEART INFARCTION; ARTICLE; DEATH; HEART DISEASE; HOSPITAL ADMISSION; HUMAN; META ANALYSIS; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROGNOSIS; REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTEMATIC REVIEW; URIC ACID BLOOD LEVEL;

BIOLOGICAL MARKERS; FOLLOW-UP STUDIES; HUMANS; LENGTH OF STAY; MYOCARDIAL INFARCTION; PATIENT ADMISSION; PROGNOSIS; SURVIVAL RATE; TIME FACTORS; URIC ACID; WORLD HEALTH;

EID: 84862523240     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2012.53.162     Document Type: Article

References (23)

1. Wu XW, Muzny D, Lee C, Caskey C. Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol. 1992;34:78-84.
2. Pacher P, Nivorozhkin A, Szabo C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurionol. Pharmacol Rev. 2006;58:87-114.
3. Feig DI, Kang D-H, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359:1811-21.
4. Lippi G, Montagnana M, Franchini M, Favaloro EJ, Targher G. The paradoxal relationship between serum uric acid and cardiovascular disease. Clin Chim Acta. 2008;392:1-7.
5. Johnson RJ, Kang D-H, Feig DI, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disesas? Hypertension. 2003;41:1183-90.
6. Duan X, Ling F. Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure? Med Hypotheses. 2008;70:578-81.
7. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2010;62:170-80.
8. Kojima S, Sakamoto T, Ishihara M, Kimura K, Miyazaki S, Yamagishi M, et al. Japanese acute coronary syndrome study (JACSS) investigators. Prognostic usefulness of serum uric acid after acute myocardial infarction. Am J Cardiol. 2005;96:489-95.
9. Car S, Trkulja V. Higher serum uric acid on admission is associated with higher short-term mortality and poorer long-term survival after myocardial infarction: retrospective prognostic study. Croat Med J. 2009;50:559-66.
10. Lazzeri C, Valente S, Chiostri M, Sori A, Bernardo P, Gensini GF. Uric acid in the acute phase of ST elevation myocardioal infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience. Int J Cardiol. 2010;138:206-9.
11. Kowalczyk J, Francuz P, Swoboda R, Lenarczyk R, Sredniawa B, Golda A, et al. Prognostic significance of hyperuricemia in patients with different types of renal dysfunction after acute myocardial infarction treated with percutaneous coronary intervention. Nephron Clin Pract. 2010;116:c114-22.
12. Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF. Uric acid in the early risk stratification of ST-elevation myocardial infarction. Intern Emerg Med. 2012;7:33-9.
13. Basar N, Sen N, Ozcan F, Erden G, Kanat S, Sokmen E. Elevated serum uric acid predicts angiographic impaired reperfusion and 1-year mortality in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention. J Investig Med. 2011;59:931-7.
14. Bae MH, Lee JH, Lee SJ, Park SH, Yang DH, Park HS, et al. Serum uric acid as an independent and incremental prognostic marker in addition to N-terminal pro-B-type natriuretic peptide in patients with acute myocardial infarction. Circ J. 2011;75:1440-7.
15. Akpek M, Kaya MG, Uyarel H, Yarlioglues M, Kalay N, Gunebakmaz O, et al. The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI. Atherosclerosis. 2011;219:334-41.
16. Kaya MG, Uyarel H, Akpek M, Kalay N, Ergelen M, Ayhan E, et al. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol. 2012;109:486-91.
17. Valente S, Lazzeri C, Vecchio S, Giglioli C, Mergheri M, Bernardo P, et al. Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock. Int J Cardiol. 2007;114:176-82.
18. Homayounfar S, Ansari M, Kashani KM. Evaluation of independent prognostic importance of hyperuricemia in hospital death after acute myocardial infarction. Saudi Med J. 2007;28:759-61.
19. Rentoukas E, Tsarouhas K, Tsitsimpikou C, Lazaros G, Deftereos S, Vavetsi S. The prognostic impact of allopurinol in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Int J Cardiol. 2010;145:257-8.
20. Spoon DB, Lerman A, Rule AD, Prasad A, Lennon RJ, Holmes DR, et al. The association of serum uric acid levels with outcomes following percutaneous coronary intervention. J Interv Cardiol. 2010;23:277-83.
21. Park SH, Shin WY, Lee EY, Gil HW, Lee SW, Lee SJ, et al. The impact of hyperuricemia on in-hospital mortality and incidence of acute kidney injury in patients undergoing percutaneous coronary intervention. Circ J. 2011;75:692-7.
22. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle K, Cannon CP, et al. Predictors of hospital mortality in the Global registry of acute coronary events. Arch Intern Med. 2003;163:2345-53.
23. Halkin A, Singh M, Nikolsky E, Grines CL, Tcheng JE, Garcia E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction. The Cadillac risk score. J Am Coll Cardiol. 2005;45:1397-405.